[ET Net News Agency, 21 June 2021] WUXI BIO (02269) rose 4.92% to HK$138.6.
It hits an intra-day high of HK$138.8, hitting a historical high, and an intra-day low
of HK$129.5. The total shares traded was 4.42 million, with a value of HK$588.6m. The
active buy/sell ratio is 64:36, with net buying turnover of HK$119.69m. CHINA INNOVATION
MARKET SER accounts for greatest net responsive buying turnover of HK$16.58m, with volume
weighted average price of HK$135.501. MERRILL LYNCH FE accounts for greatest net
responsive selling turnover of HK$17.33m, with volume weighted average price of
HK$134.502. The stock has risen a combined 18.56% over the past 3 consecutive trading
days.
The Hang Seng Index now fell 313 points, or 1.09% to 28,487; the Hang Seng China
Enterprises Index now fell 98 points, or 0.93% to 10,547; the Hang Seng TECH Index now
fell 102 points, or 1.28% to 7,938; with an overall turnover of HK$19.84b.
The SSE Composite Index now fell 6 points, or 0.18% to 3,518, with an overall turnover
of RMB60.09b.
The SZSE Component Index now fell 4 points, or 0.03% to 14,579, with an overall turnover
of RMB40.11b.
Basic Information
-------------------------------------------
Nominal 138.600 % Chg +4.92%
High 138.800 Low 129.500
Shares Tr 4.42m Turnover 588.6m
10-D SMA 123.970 %H.V 54.042
20-D SMA 121.395 VWAP 133.285
50-D SMA 112.836 RSI14 70.685
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 64:36, with net buying
turnover of HK$119.69m, rising a combined 18.56% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 138.60 +4.92
GENSCRIPT BIO (01548) 32.05 -2.44
INNOVENT BIO (01801) 85.25 -1.50
JXR (01951) 19.76 +7.39
JW THERAP-B (02126) 29.80 +5.30
CARSGEN-B (02171) 31.10 +3.67
CSTONE PHARMA-B (02616) 18.00 +6.01
BEIGENE (06160) 193.40 +0.83
CANSINOBIO-B (06185) 359.60 +0.73
ALPHAMAB-B (09966) 22.60 +6.35
-------------------------------------------------
(ed)